> News > GenomSys and Philips join forces for novel genomic analysis solutions

GenomSys and Philips join forces for novel genomic analysis solutions

GenomSys has signed a multi-year development and license agreement with Philips, a global leader in health technology, to develop tools and software compliant with the ISO/IEC 23092 MPEG-G international open standard for genome sequencing. These tools will support the efficient representation of genomics data and advanced data analysis applications for diagnostic and treatment of patients worldwide, with a specific focus on oncology.

The collaboration between Philips and GenomSys is already effective and will see Philips scientists using the Biopôle based startup technology for genome sequencing data processing in their environment.

“We are excited about this collaboration with one of the major international players in the health technology space. We are honored for the trust that Philips puts in GenomSys and in our innovative solutions, a clear confirmation of the value of our developments and applications in the genomic field”, says Alessio Ascari, CEO of GenomSys.

Both GenomSys and Philips have been among the leading contributors and supporters in the development process of MPEG-G from its inception. This collaboration represents a further step, as the two companies will be joining their efforts in genomic analysis solutions based on the new MPEG-G standard and implementing the tools and software leveraging its benefits - efficient compression, guaranteed interoperability, native protection, unified syntax, and selective access for fast and efficient analyses.

The agreement includes Philips granting GenomSys a sole license to its MPEG-G patents, which will then be integrated into GenomSys' offer to provide customers with even more comprehensive solutions. Conversely, Philips will be allowed to integrate GenomSys MPEG-G-based software and analytical tools into its genomic platforms.

See original press release on startupticker.ch.

Company related to the news